Manna+Elisha FAQ's

AHCC, short for Active Hexose Correlated Compound, is a potent extract derived from shiitake mushrooms. Crafted through a unique extraction process, it yields a highly bioactive compound packed with alpha-glucans, renowned for its immune-regulating properties.

AHCC's immune-boosting effects typically manifest within four weeks, as demonstrated in a trial involving 36 adults. Furthermore, it showed promising results in suppressing HPV infections within three to six months, as observed in a study involving 41 females.

Consulting with a healthcare professional is advisable before starting any supplement regimen to ensure suitability and dosage accuracy appropriate for your individual needs. AHCC dosages vary depending on intended use, with typical daily doses ranging from 1 to 3 grams. Clinical trials have utilized varying doses for specific purposes, such as immune support, liver health, and cancer management. Some doses used in clinical trials include the following: - 1 gram a day for immune system support - 1–3 grams a day for alcohol-induced increased liver enzymes - 3 grams a day for HPV - 3 grams a day for liver cancer - 6 grams a day for pancreatic cancer

Preliminary findings from a small study suggest that AHCC effectively cleared persistent HPV infections in nearly 60% of females who incorporated it into their regimen. However, larger clinical trials are needed to validate this promising effect.

When considering AHCC supplementation, it's essential to exercise caution and consider the following: - Allergies: Individuals with mushroom allergies should approach AHCC with caution due to potential hypersensitivity reactions. - Pregnancy and Breastfeeding: AHCC's safety during pregnancy and breastfeeding hasn't been sufficiently studied, so it's best to avoid it during these periods and consult with a healthcare provider. - Children: AHCC hasn't been studied in children, thus it's not recommended for pediatric use without consulting a pediatrician. Immediate medical attention should be sought if experiencing severe allergic reactions.

While AHCC may have potential side effects, the available safety data suggests they are rare and typically mild, such as nausea, bloating, fatigue, and heartburn. Importantly, one clinical trial reported that side effects were similar between AHCC and placebo groups, highlighting its overall tolerability.

AHCC may interact with certain medications, including Femara (letrozole) used for breast cancer treatment, as it was found to decrease Femara's effectiveness in a mouse model. Additionally, drugs metabolized by cytochrome P450 2D6, such as Adriamycin (doxorubicin) and Decadron (dexamethasone), may experience altered levels when taken concurrently with AHCC. The possible interactions with medications mentioned here are however not intended to be comprehensive. It is essential to consult with your healthcare provider regarding potential interactions and carefully review supplement labels for ingredient details.